Medibank Private Limited (ASX: MPL) - Share Price
Current share price for MPL : $4.850 0.05 (1.02%)+
Medibank Private Limited (MPL), an ASX-listed company, is a private health insurer, underwriter and distributes private health insurance policies under its two brands, Medibank and ahm. The Group also provides a range of virtual health, home care, preventative health and primary care services through its Amplar Health division, which includes the Myhealth medical clinics.
MPL General Information +
| ASX Code | MPL |
| Website | http://medibank.com.au |
| Industry/Sector | Life & Health Insurance |
| Market Cap ($M) | 13,356 |
| MPL Share Price | $4.850 |
| Day High | $4.905 |
| Day Low | $4.845 |
| Last Close | $4.900 |
| MPL Share Price Movement | $0.05 ( 1.02% ) |
Prices as at 16:40, 19 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Medibank Private Limited (MPL) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| Result | 8.3¢ | 100% | 26 Feb 2026 | 18 Mar 2026 | - | - | - |
| HFResult | 10.2¢ | 100% | 10 Sep 2025 | 9 Oct 2025 | - | - | - |
| Result | 7.8¢ | 100% | 6 Mar 2025 | 26 Mar 2025 | - | - | - |
See all dividends from Medibank Private Limited (MPL) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Medibank Private Limited (MPL) price-sensitive announcements
MPL - HY26 Results - Investor Presentation
Medibank Private Limited's HY26 results showcase a solid financial performance with a grou
Medibank Private Limited (MPL)
19 Feb 2026 | 7:41 AM
19 Feb 2026 | 7:41 AM
MPL - HY26 Results - Media Release
Medibank Private Limited reported its 2026 half-year results showing strong growth driven
Medibank Private Limited (MPL)
19 Feb 2026 | 7:39 AM
19 Feb 2026 | 7:39 AM
MPL - HY26 Results - Appendix 4D and Financial Report
Medibank Private Limited's half-year financial report for the period ending 31 December 20
Medibank Private Limited (MPL)
19 Feb 2026 | 7:35 AM
19 Feb 2026 | 7:35 AM
MPL - Medibank to acquire Better Medical
Medibank Private Limited announced the acquisition of Better Medical, a network consisting
Medibank Private Limited (MPL)
5 Nov 2025 | 7:55 AM
5 Nov 2025 | 7:55 AM
Medibank Private Limited (MPL) Recent ASX Announcements
MPL Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026F | $674.48 | $24.49 | 6.40% | 16.17 | 19.50 | 4.92% | 100.0% |
| 2025F | $633.91 | $23.02 | 29.80% | 17.20 | 18.50 | 4.67% | 100.0% |
| 2024A | $570.10 | $17.74 | -4.40% | 20.30 | 16.60 | 4.61% | 100.0% |
MPL Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | ||
| Generation Development Group Limited (GDG) | $1,424M | 1.6612 | -0.2253 | 0.2091 | 24.2342 | 31.2830 | 25.8721 | 0.56% | 1.12% | 1.54% |
| Medibank Private Limited (MPL) | $13,495M | 0.0201 | 0.1986 | 0.1113 | 24.7600 | 20.6577 | 18.5888 | 3.67% | 4.00% | 4.49% |
| NIB Holdings Limited (NHF) | $3,418M | -0.0761 | -0.0164 | 0.1463 | 16.8800 | 17.1618 | 14.9711 | 4.15% | 4.14% | 4.66% |
MPL Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.63 | 20.50 | 5.72 | 1.33 |
| Market | 0.29 | 13.20 | 1.17 | 0.67 |
| Sector | 0.56 | 16.40 | 2.02 | 2.04 |
MPL Directors
| Name | Position | Start Date |
|---|---|---|
| Mr David Koczkar | Chief Executive Officer, Managing Director | 17 May 2021 |
| Ms Kathryn Joy Fagg | Non-Executive Director | 31 Mar 2022 |
| Dr Lisa Margaret McIntyre | Non-Executive Director | 19 Nov 2025 |
| Ms Jacqueline Cherie Hey | Non-Executive Director | 19 Nov 2025 |
| Mr Peter Dobie Everingham | Non-Executive Director | 31 Mar 2022 |
| Dr Tracey Leigh Batten | Non-Executive Director | 28 Aug 2017 |
| Mr Gerard Dalbosco | Non-Executive Director | 21 May 2021 |
| Mr Michael (Mike) John Wilkins | Non-Executive Director, Non-Executive Chairman | 25 May 2017 |
Medibank Private Limited (MPL) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 2 Mar 2026 | HEY, Jacqueline | Buy | Indirect Shares | 11,448 | $4.420 | $50,600.160 |
| 27 Feb 2026 | EVERINGHAM, Peter | Buy | Indirect Shares | 25,000 | $4.410 | $110,250.000 |
| 23 Feb 2026 | MCINTYRE, Lisa | Buy | Indirect Shares | 22,370 | $4.480 | $100,217.600 |
See all changes in directors' interest & trades for Medibank Private Limited (MPL) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
MPL Management
| Name | Position |
|---|---|
| Milosh Milisavljevic | Chief Customer Officer |
| Mark Rogers | Chief Financial Officer and Group Strategy |
| Tom Exton | Chief Risk and Compliance Officer |
| Felicia Trewin | Data and Technology |
| Mei Ramsay | Group General Counsel,Company Secretary |
| Rob Read | Group Lead - Amplar Health |
| Kylie Bishop | People, Spaces and Sustainability |
| Meaghan Telford | Policy, Advocacy and Reputation |
MPL Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Medibank Private Limited (MPL). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 214,144,438 (7.78%) | Australiansuper Pty Ltd |
| 201,490,011 (7.32%) | State Street Corporation and subsidiaries |
| 193,895,716 (7.04%) | BlackRock Group |
| 165,447,082 (6.01%) | The Vanguard Group,Inc |
MPL Calendar of Events
| Date | Event |
|---|---|
| 18 February 2027 | Report (Interim) |
| 18 September 2026 | Report (Annual) |
| 27 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
